Skip to main content
AZN logo
AZN
(NYSE)
AstraZeneca PLC
$183.92-- (--)
Loading... - Market loading

AstraZeneca (AZN) Stock Price & Financial Analysis

AstraZeneca Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$182.67 - $184.74
52-Week High$212.71
52-Week Low$66.16
Open$183.43
Volume1.22M
Average Volume (3M)1.95M
Market Cap566.89B
Shares Outstanding3.12B
P/E Ratio (TTM)54.57
Forward P/E41.57
Price to Sales (P/S)9.38
Price to Book (P/B)11.98
EV/EBITDA29.38
Revenue (TTM)60.44B
Net Income (TTM)10.39B
Free Cash Flow (TTM)8.79B
EPS (TTM)$3.33
Profit Margin17.19%
Operating Margin23.69%
Return on Equity (ROE)21.95%
Debt to Equity0.68
50-Day MA$192.91
200-Day MA$148.31
52-Week Change163.76%
Annual Dividend$7.43
Dividend Yield4.04%
Payout Ratio200.00%
Last Dividend Ex-DateMar 23, 2027

Frequently Asked Questions About AstraZeneca

What is the current stock price for AZN?

As of the latest trading session, AZN stock trades at $183.92. The 52-week range is $66.16–$212.71, with a day range of $182.67–$184.74.

What is the P/E ratio for AZN?

AstraZeneca's trailing P/E ratio is 54.6, meaning investors pay $54.6 for every $1 of annual earnings. The forward P/E is 41.6, reflecting analyst expectations for future earnings. AstraZeneca operates in the Healthcare sector.

Does AZN pay dividends?

Yes, AstraZeneca pays a 4.04% annual dividend yield ($7.43 per share). The payout ratio is 200.0%. The last ex-dividend date was 2027-03-23.

What do analysts recommend for AZN?

Based on 12 analysts, the consensus for AZN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AZN?

AstraZeneca's market capitalization is $574.20B, classifying it as a mega-cap company. AstraZeneca operates in the Healthcare sector within the Drug Manufacturers - General industry.